Literature DB >> 10596863

The possible role of plasma kallikrein-kinin system and leukocyte elastase in pathogenesis of schizophrenia.

I Shcherbakova1, E Neshkova, V Dotsenko, T Platonova, E Shcherbakova, G Yarovaya.   

Abstract

The main purpose of this paper is to study the possible causes of blood-brain barrier (BBB) damage during the acute condition of schizophrenia (Sch), which makes brain antigens accessible to the immunocompetent cells. The development of autoimmune reactions in this disease has to be preceded by the damage of BBB. We have studied the level of activity of plasma kallikrein-kinin (KKS) and complement systems, C-reactive protein (CRP) concentration, proteinase inhibitory potential as well as the oxidized and degranulating activity of neutrophils as the main factors affected the permeability of tissue-blood barrier. Our results suggested that the acute stage of Sch was accompanied by the activation of KKS on the background of enhance in the functional activity of the alpha-1-proteinase inhibitor. The increased level of CRP, the high haemolytic activity of complement and significant degranulating activity of polymorphonuclear leukocytes testified to inflammatory character of Sch. The treatment with psychotropic drugs have led to decrease of polymorphonuclear elastase (PMN-E) activity in patient's plasma. Our in vitro study indicates that Haloperidol causes the lowering of PMN-E activity in the dose-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596863     DOI: 10.1016/s0162-3109(99)00099-5

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  10 in total

Review 1.  The complement system in schizophrenia.

Authors:  Karine R Mayilyan; Daniel R Weinberger; Robert B Sim
Journal:  Drug News Perspect       Date:  2008-05

2.  Blockade of the kinin B1 receptor affects the cytokine/chemokine profile in rat brain subjected to autoimmune encephalomyelitis.

Authors:  Karolina Podsiadło; Grzegorz Sulkowski; Beata Dąbrowska-Bouta; Lidia Strużyńska
Journal:  Inflammopharmacology       Date:  2017-02-03       Impact factor: 4.473

3.  Immunolocalization of plasma kallikrein in human brain.

Authors:  M E Cerf; D M Raidoo
Journal:  Metab Brain Dis       Date:  2000-12       Impact factor: 3.584

Review 4.  The complement system in schizophrenia: where are we now and what's next?

Authors:  Julia J Woo; Jennie G Pouget; Clement C Zai; James L Kennedy
Journal:  Mol Psychiatry       Date:  2019-08-22       Impact factor: 15.992

5.  Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.

Authors:  Konasale M Prasad; Kodavali V Chowdari; Leonardo A D'Aiuto; Satish Iyengar; Jeffrey A Stanley; Vishwajit L Nimgaonkar
Journal:  Transl Psychiatry       Date:  2018-07-19       Impact factor: 6.222

6.  Kininogen-1 as a protein biomarker for schizophrenia through mass spectrometry and genetic association analyses.

Authors:  Mingjia Yang; Na Zhou; Huiping Zhang; Guojun Kang; Bonan Cao; Qi Kang; Rixin Li; Xiaojing Zhu; Wenwang Rao; Qiong Yu
Journal:  PeerJ       Date:  2019-07-18       Impact factor: 2.984

Review 7.  Schizophrenia: Complement Cleaning or Killing.

Authors:  Jirrine T T Hogenaar; Hans van Bokhoven
Journal:  Genes (Basel)       Date:  2021-02-11       Impact factor: 4.096

8.  A significant causal association between C-reactive protein levels and schizophrenia.

Authors:  Masatoshi Inoshita; Shusuke Numata; Atsushi Tajima; Makoto Kinoshita; Hidehiro Umehara; Masahito Nakataki; Masashi Ikeda; Souichiro Maruyama; Hidenaga Yamamori; Tetsufumi Kanazawa; Shinji Shimodera; Ryota Hashimoto; Issei Imoto; Hiroshi Yoneda; Nakao Iwata; Tetsuro Ohmori
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

Review 9.  The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.

Authors:  V L Nimgaonkar; K M Prasad; K V Chowdari; E G Severance; R H Yolken
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

10.  C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.

Authors:  Isabella Jacomb; Clive Stanton; Rohini Vasudevan; Hugh Powell; Maryanne O'Donnell; Rhoshel Lenroot; Jason Bruggemann; Ryan Balzan; Cherrie Galletly; Dennis Liu; Cynthia S Weickert; Thomas W Weickert
Journal:  Front Immunol       Date:  2018-10-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.